SDS Optic begins the operation of its new R&D center in the US

January 16, 2024

SDS Optic S.A. is starting work at its new R&D center in the United States. On January 16, 2024, its subsidiary, SDS Optic Inc., signed an agreement with BioLabs Philadelphia LLC for the rental of office and laboratory space. BioLabs offers SDS Optic Inc., among other things, flexible lease terms, comprehensive equipment, and operational support services during experimental work.

The R&D Center of SDS Optic Inc. will operate in the central part of Philadelphia, right next to the historic Liberty Bell Center and Independence Hall, where the Declaration of Independence and the U.S. Constitution were drafted and adopted. In recent months, SDS Optic Inc. has completed all necessary registrations with U.S. public and financial institutions required to conduct business. The company's accounts and related services will be provided by Citizens Bank NA, based in Boston, MA, while Baker Tilly US Advantage Services will offer support in accounting, taxation, human resources, payroll, and financial reporting.

Recruitment processes are currently underway, aimed at hiring research and development employees. The company has already signed an employment contract (the so-called Employment Offer Letter Agreement), under which the Principal Investigator will begin working for SDS Optic USA on January 22, 2024. The employee’s role will involve the daily coordination of the operations of the USA R&D Center and the direct management of the team conducting research and development work in the field of molecular biology to develop further applications of the inPROBE technology.

Dr. hab. in medical sciences, Eng. Magdalena Staniszewska, Professor at KUL – Director of R&D at SDS Optic S.A. "This is an exciting moment and new opportunities for the R&D team and the entire SDS Optic company. We are counting on further development of our technology and its use in additional diagnostic areas. The increase in scientific and research potential, thanks to the additional competencies brought by the new members of the R&D center in the USA, will allow for the exchange of experiences between the teams working on both sides of the ocean, which will contribute to the introduction of interesting solutions during the implementation of planned research work."

BioLabs Philadelphia is a modern laboratory and office space divided into comfortable and practical workstations. The entire available infrastructure guarantees comprehensive support within the ecosystem of the best biotechnology companies in the region, ranging from individual workstations, private laboratories and rooms, to additional services. SDS Optic S.A. has been announcing the opening of a R&D center in the United States for some time. The work of the new laboratory will be supported by the Scientific Advisory Board, which includes distinguished scientists and doctors from Poland and the USA. The Board, chaired by Dr. hab. n. med. Eng. Magdalena Staniszewska, Professor at KUL, will also support the laboratory's activities in the USA. The Polish company is thus achieving another milestone and advancing in the commercialization process of the inPROBE technology, in which another American entity, Clarfield International from New York, actively participates.

According to Mateusz Sagan, the Chief Operating Officer and Director of Operations at SDS Optic S.A. "A company in the United States will create another strong point of contact for potential partners with the SDS Optic brand, increase the company’s credibility across the ocean, and make it easier to establish relationships with large corporations locally. The location of our laboratory right next to Independence Hall, where the US as we know it today was actually founded, is also very symbolic for us, and we are very optimistic about the development of SDS Optic in the US."

Source: SDS Optic S.A. | January 16, 2024

We Care About Your Privacy

SDS Optic S.A. uses cookies to improve and customize users experience on our website. By selecting 'Accept', you consent to the use of all cookies that gather and use information about your interactions with our site to provide personalized content and enhance your digital experience. Please read our Privacy Policy for more information.